113 filings
Page 3 of 6
8-K
lspxlgvhfy051zaheq
9 Sep 21
Novan Announces Strategic Priorities and Outlines Key Milestones
7:05am
8-K
k5gfg9 q8
12 Aug 21
Novan Reports Second Quarter 2021 Financial Results and Provides Corporate Update
8:11am
8-K
8552i eqvm27hrcf3b
21 Jun 21
Entry into a Material Definitive Agreement
4:10pm
8-K
k36cf
21 Jun 21
Termination of a Material Definitive Agreement
8:00am
8-K
4o6wopa2
11 Jun 21
Novan Reports Positive Topline Results from Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
6:41am
8-K
ap1v sfz73a62e5
10 Jun 21
Novan Announces Positive Preclinical Data in SB019 COVID-19 Anti-Viral Therapy Program
8:40am
8-K
g7quksl7pdm3jf4g1
7 Jun 21
Other Events
8:42am
8-K
hgh vmq0h19evsxqf
25 May 21
Novan Announces 1-for-10 Reverse Stock Split
8:06am
8-K
k1lew79f95
11 May 21
Novan Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:09pm
8-K
8ra5otpb9pdj
6 May 21
Departure of Directors or Certain Officers
4:30pm
8-K
l0pzs
9 Mar 21
Other Events
7:01am
8-K
v3e648z3srij97xys
2 Mar 21
Novan Bolsters Commercialization Expertise with Election of Steven D. Skolsky to Board of Directors
8:41am
8-K
gthz6
25 Feb 21
Novan Reports Full Year 2020 Financial Results and Provides Corporate Update
7:40am
8-K
gm8crf8b0d505s33z
29 Jan 21
Other Events
4:08pm
8-K
e9a4b1ijb1u19x98
19 Jan 21
Entry into a Material Definitive Agreement
9:05am
8-K
v0m6 pkq829t0
4 Nov 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:35am
8-K
d0pldnlg yna
30 Oct 20
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:36am
8-K
pjl hl7rj0
14 Oct 20
Other Events
7:06am
8-K
mskhx
24 Sep 20
Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
7:10am
8-K
aj3d0mgrb
14 Sep 20
Novan Provides Pipeline and Priority Development Programs Update
9:08am